Podcast Date:
Monday, December 28, 2020 - 08:22
Research and theory have led to the development of empirically-supported options for SUD treatment, both psychosocial and pharmacological. However, these treatments only have moderate efficacy/effectiveness, and some aspects of treatments may be more implicated for some than others. Tori Votaw talks about precision medicine, which is determining which treatments work best for subgroups of individuals. Specifically, Tori discusses her work in understanding phenotypes of addiction such as negative emotionality and executive functioning that may help classify individuals into different specific treatment approaches. Tori Votaw is a graduate student and T32 predoctoral fellow in the Department of Psychology at the University of New Mexico.
